A5050490207- Cervical Cancer and HPV Research
- Genital Health and Disease
- Endometrial and Cervical Cancer Treatments
- Genetic factors in colorectal cancer
- Molecular Biology Techniques and Applications
- Head and Neck Cancer Studies
- Helicobacter pylori-related gastroenterology studies
- Hepatitis B Virus Studies
- Colorectal and Anal Carcinomas
- Cancer-related Molecular Pathways
- Reproductive tract infections research
- Gastric Cancer Management and Outcomes
- Global Cancer Incidence and Screening
- Oral Health Pathology and Treatment
- Colorectal Cancer Screening and Detection
- Breast Cancer Treatment Studies
- Colorectal Cancer Treatments and Studies
- Cancer-related molecular mechanisms research
- Ovarian cancer diagnosis and treatment
- Cancer Genomics and Diagnostics
- Esophageal Cancer Research and Treatment
- Eosinophilic Esophagitis
- Virus-based gene therapy research
- Forest Ecology and Biodiversity Studies
- Immunotherapy and Immune Responses
Hospital de Câncer de Barretos
2016-2025
University of Oulu
2025
Biocenter Finland
2015-2023
Finnish Environment Institute
2006-2023
Turku University Hospital
2010-2022
Sartorius (United Kingdom)
2022
University of Turku
2008-2021
Molecular Oncology (United States)
2021
Orion Corporation (Finland)
2012-2020
University of Minho
2005-2018
Abstract The APTIMA® HPV Assay (AHPV) allows detection of 14 high‐risk human papillomavirus (HPV) RNA types in cervical specimens. Until present, the assay has been compared to DNA tests only triage settings. Herein, we compare AHPV with a (Hybrid Capture® 2; HC2) and liquid‐based cytology (LBC; using PreservCyt® ThinPrep liquid Pap) screening setting (French APTIMA evaluation [FASE] study). Women ( N = 5,006) aged 20–65 were screened by gynecologists 17 private practices Paris, France. One...
Characteristic cytokine patterns have been described in different cancer patients and they are related to their diagnosis, prognosis, prediction of treatment responses survival. A panel cytokines was evaluated the plasma non-small cell lung (NSCLC) healthy controls investigate profile relationship with clinical characteristics overall The case-controlled cross-sectional study design recruited 77 confirmed diagnosis NSCLC (cases) 91 subjects (controls) aimed examine peripheral...
Background: Increased demand of the serological biomarker test (GastroPanel®) in non-invasive diagnosis gastric cancer (GC) risk conditions, i.e., atrophic gastritis (AG) and Helicobacter pylori (Hp) infection, prompted design GastroPanel® Quick (GPQT) (Biohit Oyj, Helsinki, Finland) for point-of-care (POC) settings. Objective: This study validated diagnostic accuracy (DA) GPQT AG Hp among gastroscopy referral patients. Methods: Altogether, 266 patients were enrolled consecutive referrals at...
The authors derived prevalence and incidence figures for cervical human papillomavirus (HPV) infections in an unselected Finnish population of women aged 22. This paper is epidemiologic study utilizing the mass-screening program that has been conducted Finland cancer since early 1960s. estimated lifetime risk HPV based on this those from a random sample 2,084 (out 28,861) routine Papanicolaou (Pap) smears examined their laboratory. was performed between 1985-1986 focusing total cohort...
Objectives: To assess the performance indicators of visual inspection with acetic acid (VIA) and Lugol's iodine (VILI) in four Latin American centres participating ongoing AMerican Screening (LAMS) study, settings moderate incidence cervical disease poorly to moderately well-organized cancer screening. Setting: Three Brazilian (São Paulo, Campinas Porto Alegre) one Argentine centre (Buenos Aires) recruited a total 11,834 healthy women undergo VIA, VILI, conventional Pap smear Hybrid Capture...
Abstract. The forest structure in a large, relatively homogeneous area of pristine Picea abies taiga the southern boreal region west Ural mountains was studied along four 500‐m long transects. P. dominated association with Abies sibirica and Betula spp. mean volume living trees 216 m 3 /ha. This value varied among transects, from 138 ‐ 252 Mean density (DBH > 1 cm) (and variation over transects) 2 064/ha (1670 2710). Living classified as dying or seriously damaged made up 2.9 (2.5 3.5) %...